The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas.
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis*; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D005951:Glucose Tolerance Test; D006400:Hematocrit; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007930:Leucine; D007958:Leukocyte Count; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013046:Specific Gravity; D013448:Sulfobromophthalein; D014044:Tolbutamide / Q000627:therapeutic use; D014556:Urine
D000903:Antibiotics, Antineoplastic; D001786:Blood Glucose; D002712:Chlorides; D007328:Insulin; D013448:Sulfobromophthalein; D002245:Carbon Dioxide; D014044:Tolbutamide; D012964:Sodium; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D007930:Leucine; D011188:Potassium